227 related articles for article (PubMed ID: 17366791)
1. [Clinical significance of serum proteomic patterns in diagnosis of breast cancer].
Liu DH; Zhang LM; Feng WY
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):770-1. PubMed ID: 17366791
[No Abstract] [Full Text] [Related]
2. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
3. [Application of serum proteomics in breast cancer research].
Zhu ZM; Hu XF; Zeng R
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):561-5. PubMed ID: 18210871
[No Abstract] [Full Text] [Related]
4. [Proteic profiling SELDI-TOF and breast cancer: clinical potential applications].
Gonçalves A; Bertucci F; Birnbaum D; Borg JP
Med Sci (Paris); 2007 Mar; 23 Spec No 1():23-6. PubMed ID: 17669349
[TBL] [Abstract][Full Text] [Related]
5. Serum proteomic profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for cancer diagnosis: next steps.
Diamandis EP
Cancer Res; 2006 Jun; 66(11):5540-1. PubMed ID: 16740686
[No Abstract] [Full Text] [Related]
6. Use of serological proteomic methods to find biomarkers associated with breast cancer.
Rui Z; Jian-Guo J; Yuan-Peng T; Hai P; Bing-Gen R
Proteomics; 2003 Apr; 3(4):433-9. PubMed ID: 12687611
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic application of serum protein pattern and artificial neural network software in breast cancer].
Hu Y; Zhang SZ; Yu JK; Liu J; Zheng S; Hu X
Ai Zheng; 2005 Jan; 24(1):67-71. PubMed ID: 15642203
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of serum proteomic profiling before and after cervical cancer surgery].
Shao ZY; Zheng ZG; Lou HM; Zhang P
Zhonghua Fu Chan Ke Za Zhi; 2009 May; 44(5):374-8. PubMed ID: 19573315
[TBL] [Abstract][Full Text] [Related]
10. MALDI-TOF serum protein profiling for the detection of breast cancer.
de Noo ME; Deelder A; van der Werff M; Ozalp A; Mertens B; Tollenaar R
Onkologie; 2006 Nov; 29(11):501-6. PubMed ID: 17068384
[TBL] [Abstract][Full Text] [Related]
11. Proteomic approaches for cancer biomarker discovery in plasma.
Pitteri SJ; Hanash SM
Expert Rev Proteomics; 2007 Oct; 4(5):589-90. PubMed ID: 17941811
[No Abstract] [Full Text] [Related]
12. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
He QY; Zhu R; Lei T; Ng MY; Luk JM; Sham P; Lau GK; Chiu JF
J Cell Biochem; 2008 Feb; 103(3):740-52. PubMed ID: 17557278
[TBL] [Abstract][Full Text] [Related]
13. Proteomic studies of early-stage and advanced ovarian cancer patients.
Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
[TBL] [Abstract][Full Text] [Related]
14. SELDI-TOF serum proteomics and breast cancer: which perspective?
Garrisi VM; Abbate I; Quaranta M; Mangia A; Tommasi S; Paradiso A
Expert Rev Proteomics; 2008 Dec; 5(6):779-85. PubMed ID: 19086858
[TBL] [Abstract][Full Text] [Related]
15. Distinct serumal proteomic patterns between ascending and descending types of loco-regionally advanced nasopharyngeal carcinoma assessed by surface enhanced laser desorption ionization and artificial neural network analyses.
Guo X; Cao SM; Yu JK; Hong MH; Zhang CQ; Li NW; Xiang YQ; Qian CN; Hu X; Min HQ; Zeng YX
Chin Med J (Engl); 2005 Nov; 118(22):1912-7. PubMed ID: 16313847
[No Abstract] [Full Text] [Related]
16. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
[TBL] [Abstract][Full Text] [Related]
17. [Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis].
Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):753-7. PubMed ID: 17366787
[TBL] [Abstract][Full Text] [Related]
18. [Proteomics and breast cancer].
Mathelin C; Tomasetto C; Cromer A; Rio MC
Gynecol Obstet Fertil; 2006 Dec; 34(12):1161-9. PubMed ID: 17123853
[TBL] [Abstract][Full Text] [Related]
19. Combined experimental and statistical strategy for mass spectrometry based serum protein profiling for diagnosis of breast cancer: a case-control study.
Callesen AK; Vach W; Jørgensen PE; Cold S; Tan Q; Depont Christensen R; Mogensen O; Kruse TA; Jensen ON; Madsen JS
J Proteome Res; 2008 Apr; 7(4):1419-26. PubMed ID: 18303830
[TBL] [Abstract][Full Text] [Related]
20. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]